vs
安霸(AMBA)与IONIS PHARMACEUTICALS INC(IONS)财务数据对比。点击上方公司名可切换其他公司
IONIS PHARMACEUTICALS INC的季度营收约是安霸的1.9倍($203.3M vs $108.5M),安霸净利率更高(-13.9% vs -112.8%,领先98.9%),安霸同比增速更快(31.2% vs -10.3%),安霸自由现金流更多($31.4M vs $-159.0M),过去两年安霸的营收复合增速更高(45.0% vs 30.4%)
安霸是美国无晶圆厂半导体设计企业,专注于低功耗高清、超高清视频压缩、图像处理及计算机视觉处理器研发。其芯片产品广泛应用于视频安防、高级驾驶辅助系统、电子后视镜、行车记录仪、驾驶舱内监测、自动驾驶、机器人等多元人机视觉场景。
IONIS制药是1989年成立的生物科技企业,总部位于美国加利福尼亚州卡尔斯巴德,专注于反义疗法、RNA干扰及CRISPR疗法的研发,2015年12月前曾以Isis制药的名称运营。
AMBA vs IONS — 直观对比
营收规模更大
IONS
是对方的1.9倍
$108.5M
营收增速更快
AMBA
高出41.5%
-10.3%
净利率更高
AMBA
高出98.9%
-112.8%
自由现金流更多
AMBA
多$190.4M
$-159.0M
两年增速更快
AMBA
近两年复合增速
30.4%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $108.5M | $203.3M |
| 净利润 | $-15.1M | $-229.4M |
| 毛利率 | 59.6% | 96.1% |
| 营业利润率 | -15.0% | -105.5% |
| 净利率 | -13.9% | -112.8% |
| 营收同比 | 31.2% | -10.3% |
| 净利润同比 | 37.2% | -119.8% |
| 每股收益(稀释后) | $-0.35 | $-1.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
AMBA
IONS
| Q4 25 | $108.5M | $203.3M | ||
| Q3 25 | $95.5M | $156.7M | ||
| Q2 25 | $85.9M | $452.0M | ||
| Q1 25 | $84.0M | $131.6M | ||
| Q4 24 | $82.7M | $226.6M | ||
| Q3 24 | $63.7M | $133.8M | ||
| Q2 24 | $54.5M | $225.3M | ||
| Q1 24 | $51.6M | $119.5M |
净利润
AMBA
IONS
| Q4 25 | $-15.1M | $-229.4M | ||
| Q3 25 | $-20.0M | $-128.6M | ||
| Q2 25 | $-24.3M | $123.6M | ||
| Q1 25 | $-20.2M | $-146.9M | ||
| Q4 24 | $-24.1M | $-104.3M | ||
| Q3 24 | $-34.9M | $-140.5M | ||
| Q2 24 | $-37.9M | $-66.3M | ||
| Q1 24 | $-60.6M | $-142.8M |
毛利率
AMBA
IONS
| Q4 25 | 59.6% | 96.1% | ||
| Q3 25 | 58.9% | 98.5% | ||
| Q2 25 | 60.0% | 99.1% | ||
| Q1 25 | 60.0% | 98.9% | ||
| Q4 24 | 60.6% | 98.3% | ||
| Q3 24 | 60.8% | 99.2% | ||
| Q2 24 | 60.9% | 98.2% | ||
| Q1 24 | 59.8% | 98.2% |
营业利润率
AMBA
IONS
| Q4 25 | -15.0% | -105.5% | ||
| Q3 25 | -23.0% | -102.2% | ||
| Q2 25 | -30.1% | 30.9% | ||
| Q1 25 | -30.2% | -111.6% | ||
| Q4 24 | -30.9% | -48.9% | ||
| Q3 24 | -56.9% | -111.1% | ||
| Q2 24 | -72.4% | -29.3% | ||
| Q1 24 | -80.8% | -125.1% |
净利率
AMBA
IONS
| Q4 25 | -13.9% | -112.8% | ||
| Q3 25 | -20.9% | -82.1% | ||
| Q2 25 | -28.3% | 27.3% | ||
| Q1 25 | -24.1% | -111.6% | ||
| Q4 24 | -29.1% | -46.1% | ||
| Q3 24 | -54.8% | -105.0% | ||
| Q2 24 | -69.6% | -29.4% | ||
| Q1 24 | -117.4% | -119.5% |
每股收益(稀释后)
AMBA
IONS
| Q4 25 | $-0.35 | $-1.35 | ||
| Q3 25 | $-0.47 | $-0.80 | ||
| Q2 25 | $-0.58 | $0.70 | ||
| Q1 25 | $-0.48 | $-0.93 | ||
| Q4 24 | $-0.58 | $-0.66 | ||
| Q3 24 | $-0.85 | $-0.95 | ||
| Q2 24 | $-0.93 | $-0.45 | ||
| Q1 24 | $-1.51 | $-0.98 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $174.1M | $2.7B |
| 总债务越低越好 | — | $1.8B |
| 股东权益账面价值 | $590.1M | $489.1M |
| 总资产 | $751.9M | $3.5B |
| 负债/权益比越低杠杆越低 | — | 3.71× |
8季度趋势,按日历期对齐
现金及短期投资
AMBA
IONS
| Q4 25 | $174.1M | $2.7B | ||
| Q3 25 | $142.7M | $2.2B | ||
| Q2 25 | $141.3M | $2.3B | ||
| Q1 25 | $144.6M | $2.1B | ||
| Q4 24 | $127.1M | $2.3B | ||
| Q3 24 | $153.9M | $2.5B | ||
| Q2 24 | $131.8M | $2.1B | ||
| Q1 24 | $144.9M | $2.2B |
总债务
AMBA
IONS
| Q4 25 | — | $1.8B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
AMBA
IONS
| Q4 25 | $590.1M | $489.1M | ||
| Q3 25 | $576.5M | $618.0M | ||
| Q2 25 | $572.7M | $631.7M | ||
| Q1 25 | $561.4M | $475.7M | ||
| Q4 24 | $554.3M | $588.4M | ||
| Q3 24 | $547.6M | $662.5M | ||
| Q2 24 | $555.4M | $263.7M | ||
| Q1 24 | $559.9M | $296.5M |
总资产
AMBA
IONS
| Q4 25 | $751.9M | $3.5B | ||
| Q3 25 | $706.4M | $3.0B | ||
| Q2 25 | $701.9M | $3.0B | ||
| Q1 25 | $689.0M | $2.8B | ||
| Q4 24 | $670.8M | $3.0B | ||
| Q3 24 | $650.3M | $3.1B | ||
| Q2 24 | $638.7M | $2.7B | ||
| Q1 24 | $657.7M | $2.8B |
负债/权益比
AMBA
IONS
| Q4 25 | — | 3.71× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.13× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $34.3M | $-137.7M |
| 自由现金流经营现金流 - 资本支出 | $31.4M | $-159.0M |
| 自由现金流率自由现金流/营收 | 29.0% | -78.2% |
| 资本支出强度资本支出/营收 | 2.7% | 10.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $64.3M | $-320.0M |
8季度趋势,按日历期对齐
经营现金流
AMBA
IONS
| Q4 25 | $34.3M | $-137.7M | ||
| Q3 25 | $5.5M | $-131.4M | ||
| Q2 25 | $14.8M | $151.3M | ||
| Q1 25 | $25.4M | $-150.8M | ||
| Q4 24 | $6.6M | $-116.1M | ||
| Q3 24 | $16.7M | $-115.0M | ||
| Q2 24 | $-15.0M | $-119.9M | ||
| Q1 24 | $-4.0M | $-149.9M |
自由现金流
AMBA
IONS
| Q4 25 | $31.4M | $-159.0M | ||
| Q3 25 | $1.4M | $-136.7M | ||
| Q2 25 | $10.2M | $139.0M | ||
| Q1 25 | $21.2M | $-163.4M | ||
| Q4 24 | $4.1M | $-141.6M | ||
| Q3 24 | $14.2M | $-124.0M | ||
| Q2 24 | $-16.1M | $-126.1M | ||
| Q1 24 | $-6.0M | $-154.4M |
自由现金流率
AMBA
IONS
| Q4 25 | 29.0% | -78.2% | ||
| Q3 25 | 1.4% | -87.2% | ||
| Q2 25 | 11.9% | 30.8% | ||
| Q1 25 | 25.3% | -124.1% | ||
| Q4 24 | 5.0% | -62.5% | ||
| Q3 24 | 22.2% | -92.7% | ||
| Q2 24 | -29.5% | -56.0% | ||
| Q1 24 | -11.6% | -129.2% |
资本支出强度
AMBA
IONS
| Q4 25 | 2.7% | 10.5% | ||
| Q3 25 | 4.3% | 3.4% | ||
| Q2 25 | 5.3% | 2.7% | ||
| Q1 25 | 5.0% | 9.6% | ||
| Q4 24 | 3.0% | 11.3% | ||
| Q3 24 | 4.0% | 6.8% | ||
| Q2 24 | 2.1% | 2.8% | ||
| Q1 24 | 3.7% | 3.8% |
现金转化率
AMBA
IONS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.22× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMBA
| TW | $76.0M | 70% |
| Asia Pacific Other Than Taiwan | $20.2M | 19% |
| North America Other Than United States | $7.4M | 7% |
| Other | $5.0M | 5% |
IONS
| Products | $58.0M | 29% |
| Spinraza Royalties | $54.0M | 27% |
| Collaborative Agreement Revenue | $52.4M | 26% |
| Wainus Royalties | $16.0M | 8% |
| Wainua Joint Development Revenue | $9.6M | 5% |
| Other Commercial | $7.6M | 4% |
| Other Royalties | $5.7M | 3% |